NCT02821624View on ClinicalTrials.gov

First-in-Human Safety, PK, and Food Effect Study of Single Ascending Doses of G1T38 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

December 15, 2016

Study Completion Date

April 4, 2017

Conditions
Healthy Volunteers
Interventions
DRUG

G1T38 (CDK 4/6 Inhibitor)

CDK 4/6 Inhibitor

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

PRA Early Development Clinic, Groningen

Sponsors
All Listed Sponsors
lead

G1 Therapeutics, Inc.

INDUSTRY